Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- 1 Introduction to medication errors and medication safety
- 2 Safety in prescribing
- 3 Safety in dispensing
- 4 Safety in administering
- 5 Adverse drug reactions and drug interactions
- 6 Interface of care and communication
- 7 Parenteral drug administration
- 8 Calculations
- 9 Controlled drugs and patient safety
- 10 Reporting medication errors and near misses
- 11 Ensuring safety through evidence-based medicine
- Index
- References
2 - Safety in prescribing
Published online by Cambridge University Press: 22 January 2010
Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- 1 Introduction to medication errors and medication safety
- 2 Safety in prescribing
- 3 Safety in dispensing
- 4 Safety in administering
- 5 Adverse drug reactions and drug interactions
- 6 Interface of care and communication
- 7 Parenteral drug administration
- 8 Calculations
- 9 Controlled drugs and patient safety
- 10 Reporting medication errors and near misses
- 11 Ensuring safety through evidence-based medicine
- Index
- References
Summary
Introduction
This chapter sets out the rationale for improving prescribing safety, namely the high rate of deaths, unnecessary hospital admissions and illness caused by unsafe prescribing; and what practical steps prescribers should take to reduce the risk of issuing an unsafe prescription. The tragedy in Northwick Park in 2006 when healthy volunteers suffered catastrophic consequences, albeit in the first test of a new drug, highlighted how pharmaceuticals need to be treated with caution and respect (Sunthralingham, 2006). However, it is not just new drugs which can be unsafe; drugs which have become established after many years of clinical use can also cause problems (Lasser et al., 2002). For example, after several years of use, a widely used non-steroidal anti-inflammatory drug was found to be associated with an increased risk of myocardial infarction (Solomon et al., 2004).
The first part of this chapter describes why prescribing safety is so important and this is addressed under the following four themes:
(1) Key issues for safe prescribing at the point of care. Theme one explores the safety issues that should be considered by an individual prescriber before issuing a prescription. A key message for prescribers is that they need to have the necessary information to hand at the point of prescribing: an understanding of the patient's wishes; access to a comprehensive medical record; and access to information about the drug they are about to prescribe.
[…]
- Type
- Chapter
- Information
- Medication SafetyAn Essential Guide, pp. 7 - 24Publisher: Cambridge University PressPrint publication year: 2009
References
, , , . (2003). Following Shipman: a pilot system for monitoring mortality rates in primary care. Lancet, 362(9382),485–91.CrossRefGoogle ScholarPubMed
(2008). Royal Pharmaceutical Society of Great Britain. British National Formulary (BNF) 56. RPS London, URL: http://www.bnf.org.Google Scholar
. (2005). The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med, 33(8), 1694–700.Google Scholar
, . (2006). Improving acceptance of computerized prescribing alerts in ambulatory care. Journal of the American Medical Information Association, 13(1), 5–11.Google Scholar
. (2003). The bioequivalence and therapeutic efficacy of generic versus brand-name psychoactive drugs. Clinical Therapy, 25(6), 1578–92.CrossRefGoogle ScholarPubMed
. (2000). To Err is Human: Building a Safer Health System. Washington, DC: National Academy Press. URL: http://books.nap.edu/catalog/9728.html.Google Scholar
, (2001). Institute of Medicine/ Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press, URL: http://www.nap.edu/catalog.php?record_id=10027.Google Scholar
. (2007). An educational intervention, involving feedback of routinely collected computer data, to improve cardiovascular disease management in UK primary care. Methods in Information Medicine, 46(1),57–62.Google ScholarPubMed
. (2008). Prescribing support software recommends more expensive prescriptions. Information Primary Care, 16(1), 61–2.Google ScholarPubMed
, , . (2002). A knowledge-management model for clinical practice. Journal of Postgraduate Medicine, 48(4), 297–303.Google ScholarPubMed
. (2003). The National Health Service and the internet. Journal of the Royal Society of Medicine, 96(10), 490–3.CrossRefGoogle ScholarPubMed
. (1966). Evaluating the quality of medical care. Milbank Memorial Fund Quarterly, 44(3), Suppl, 166–206.CrossRefGoogle ScholarPubMed
. (1984). Parallel imports: a pharmacist's viewpoint. British Medical Journal, (Clinical Research Education), 288(6433), 1778–9.CrossRefGoogle ScholarPubMed
. Electronic Orange Book: Approved drug products with therapeutic equivalence calculations. URL: http://www.fda.gov/cder/ob/
, , , , . (2007). The impact of a closed-loop electronic prescribing and administration system on prescribing errors, administration errors and staff time: a before-and-after study. Quality Safety in Health Care, 16(4), 279–84.CrossRefGoogle ScholarPubMed
, , , . (2008). Improving the quality of written prescriptions in a general hospital: the influence of 10 years of serial audits and targeted interventions. International Medical Journal, 38(4), 243–8.CrossRefGoogle Scholar
. Good pharmacy practice (GPP) in developing countries. Recommendations for stepwise implementation. URL: http://www.fip.nl/www2/pdf/gpp/GPP_CPS_Report.pdf
, , , , , . (2007). Errors and adverse events in family medicine: developing and validating a Canadian taxonomy of errors. Canadian Family Physician, 53(2), 271–6.Google ScholarPubMed
, , , , , . (2008). Identifying and quantifying medication errors: evaluation of rapidly discontinued medication orders submitted to a computerized physician order entry system. Journal of the American Medical Information Association, 15(4), 461–5.CrossRefGoogle ScholarPubMed
, . (2005). Identification of priorities for medication safety in neonatal intensive care. Drug Safety, 28(3), 251–61.CrossRefGoogle ScholarPubMed
, , , , , . (2002). Timing of new black box warnings and withdrawals for prescription medications. Journal of the American Medical Association, 287(17), 2215–20.CrossRefGoogle ScholarPubMed
, , et al. (2006). Adherence to black box warnings for prescription medications in outpatients. Archives of Internal Medicine, 166(3), 338–44.CrossRefGoogle ScholarPubMed
. (1956). The magical number seven, plus or minus two: some limits on our capacity for processing information. The Psychological Review, 63, 81–97.CrossRefGoogle ScholarPubMed
, . (2002). Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Medical Care, 40(8), 662–74.CrossRefGoogle ScholarPubMed
(2008). Respiratory tract infections –antibiotic prescribing; Prescribing of antibiotics for self-limiting respiratory tract infections in adults and children in primary care. NICE Clinical Guideline 69. London: NICE.Google Scholar
(2007). Safety in doses: medication safety incident in the NHS: The fourth report from the Patient Safety Observatory. London:NPSA.Google Scholar
, , , , . (2007). Rates and types of events reported to established incident reporting systems in two US hospitals. Quality Safety Health Care, 16(3), 164–8.CrossRefGoogle Scholar
, , , , . (2008). Improving the quality of medical prescriptions in neonatal units. Neonatology, 93(4), 251–6.CrossRefGoogle ScholarPubMed
, , , , , . (2005). Medical errors in primary care: results of an international study of family practice. Can Fam Physician, 51, 386–7.Google ScholarPubMed
, , . (2005). Do primary care professionals work as a team: a qualitative study. Journal of Interprofessional Care, 19(4), 396–405.CrossRefGoogle ScholarPubMed
, , et al. (2006). The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation. Archives Internal Medicine, 166(10), 1098–104.CrossRefGoogle Scholar
, , et al. (2004). Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation, 109(17), 2068–73.CrossRefGoogle ScholarPubMed
. (2006). Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. New England Journal of Medicine, 355(10), 1018–28.Google Scholar
, , , , . (2007). Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Annals of Pharmacotherapy, 41(9), 1411–26.CrossRefGoogle ScholarPubMed
, URL: (http://www.who.int/medicines/publications/essentialmedicines/en/